Shared Instrumentation Grant Program
Page 2

The types of research instruments that can be purchased under this program are nuclear magnetic resonance systems, electron and confocal microscopes, mass spectrometers, protein and DNA sequencers, biosensors, x-ray diffractometers and cell sorters.

The minimum cost of the instruments will be $100,000 each, and the maximum amount that will be granted per application will be $600,000.

The institutions and organizations that will be eligible to submit an application under the Shared Instrumentation Grant Program are the following:

a) Public/State Controlled Institutions of Higher Education

b) Private Institutions of Higher Education

c) Hispanic-serving Institutions

d) Historically Black Colleges and Universities (HBCUs)

e) Tribally Controlled Colleges and Universities (TCCUs)

f) Alaska Native and Native Hawaiian Serving Institutions

g) Nonprofit Organizations Other Than Institutions of Higher Education

The Department of Health and Human Services, the mother agency that is funding the Shared Instrumentation Grant Program, is the nation's principal agency that is largely responsible for protecting the health of all Americans and ensuring the provision of fundamental health and human services to all people needing such services.

Shared Instrumentation Grant Program
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Money Follows the Person Rebalancing Grant Demonstration Program
The Centers for Medicare & Medicaid Services has recently established the Money Follows the Person Rebalancing Grant Demonstration Program wherein they aim to assist the states to balance their long-term care systems and help Medicaid enrollees transition from institutions to communities.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Mechanisms Mediating Osteoarthritis in Aging
The National Institutes of Health, in close cooperation with The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, has recently established a program called Mechanisms Mediating Osteoarthritis in Aging in an effort to improve and encourage the characterization of new and underutilized models in order to gain a deeper understanding of mechanisms that are involved in osteoarthritic progression.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---